AKER - Akers Biosciences reports Q1 results May, 20 2019 05:44 PM Akers Biosciences Inc. Akers Biosciences (NASDAQ:AKER): Q1 operating loss of $0.90M.Cash, restricted cash and marketable securities of $5.23MPress ReleaseMore news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, ,